p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.

The p53 tumor suppressor gene is frequently mutated and the K-ras oncogene is occasionally mutated in primary specimens of human lung carcinomas. These mutated genes also cooperate in the immortalization and neoplastic transformation of rodent cells. To determine whether these mutations are necessary for maintenance of the immortalized and/or neoplastically transformed states of human bronchial epithelial cells, the p53 gene and regions of the ras (K-, H-, and N-) genes were sequenced in nine human lung carcinoma cell lines. Detection of p53 mutations by polymerase chain amplification and direct DNA sequencing was corroborated by p53 immunocytochemistry and coimmunoprecipitation of p53 with heat shock protein 70. p53 and ras genes were frequently, but not always, mutated in the carcinoma cell lines. These data are consistent with the hypothesis that multiple genetic changes involving both protooncogenes and tumor suppressor genes occur during lung carcinogenesis.

[1]  David P. Lane,et al.  Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport , 1991, Nature.

[2]  A Ciechanover,et al.  Degradation of nuclear oncoproteins by the ubiquitin system in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  B. Vogelstein.  A deadly inheritance , 1990, Nature.

[4]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[5]  R Montesano,et al.  Frequent mutation of the p53 gene in human esophageal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  W. Bodmer,et al.  p53 mutations in colorectal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Minna,et al.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. , 1990, Oncogene.

[8]  H. J. Evans,et al.  Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. , 1990, Oncogene.

[9]  M. Haas,et al.  Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines , 1990, Molecular and cellular biology.

[10]  B. Vogelstein,et al.  Suppression of human colorectal carcinoma cell growth by wild-type p53. , 1990, Science.

[11]  O. Halevy,et al.  Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 , 1990, Cell.

[12]  W. Cavenee,et al.  Mechanisms of p53 loss in human sarcomas. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[13]  E. Appella,et al.  Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Hirohashi,et al.  Association of point mutation in c‐Ki‐ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes , 1990, Cancer.

[15]  J. Minna,et al.  Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. , 1990, The Journal of clinical investigation.

[16]  Jeng-Shin Lee,et al.  Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  E. Appella,et al.  Wild type human p53 is antiproliferative in SV40-transformed hamster cells. , 1990, Oncogene.

[18]  J. Bartek,et al.  Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. , 1990, Oncogene.

[19]  W. Welch,et al.  Interaction of Hsp 70 with newly synthesized proteins: implications for protein folding and assembly. , 1990, Science.

[20]  A. Levine,et al.  Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.

[21]  A. Harris,et al.  Increased expression of mutant forms of p53 oncogene in primary lung cancer , 1990, The Lancet.

[22]  B. Vogelstein.  Cancer. A deadly inheritance. , 1990, Nature.

[23]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[24]  M. Oren,et al.  Wild-type p53 can inhibit oncogene-mediated focus formation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Pelham,et al.  Heat shock and the sorting of luminal ER proteins. , 1989, The EMBO journal.

[26]  J. Minna,et al.  p53: a frequent target for genetic abnormalities in lung cancer. , 1989, Science.

[27]  C. Harris,et al.  Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. , 1989, Cancer research.

[28]  B. Nelkin,et al.  Insertion of the v-Ha-ras oncogene induces differentiation of calcitonin-producing human small cell lung cancer. , 1989, The Journal of clinical investigation.

[29]  A. Levine,et al.  The p53 proto-oncogene can act as a suppressor of transformation , 1989, Cell.

[30]  M. Lübbert,et al.  Expression, methylation and chromatin structure of the p53 gene in untransformed and human T-cell leukemia virus type I-transformed human T-lymphocytes. , 1989, Oncogene.

[31]  C. Harris,et al.  Invasive and metastatic potential of a v-Ha-ras-transformed human bronchial epithelial cell line. , 1989, Journal of the National Cancer Institute.

[32]  D. Ledbetter,et al.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.

[33]  J. Jenkins,et al.  Ability of p53 and the adenovirus E1b 58-kilodalton protein to form a complex is determined by p53 , 1989, Journal of virology.

[34]  A. Tigges,et al.  Expression of the nuclear oncogene p53 in colon tumours , 1989, The Journal of pathology.

[35]  A. Levine,et al.  Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation , 1989, Journal of virology.

[36]  E. Appella,et al.  Specific interaction between a subset of the p53 protein family and heat shock proteins hsp72/hsc73 in a human osteosarcoma cell line. , 1988, Oncogene.

[37]  S. Rodenhuis,et al.  Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. , 1988, Cancer research.

[38]  J. Jenkins,et al.  Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen , 1988, Journal of virology.

[39]  J. Jenkins,et al.  Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells , 1988, Molecular and cellular biology.

[40]  S. Baylin,et al.  v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Rotter,et al.  Meth A fibrosarcoma cells express two transforming mutant p53 species. , 1988, Oncogene.

[42]  C. Harris,et al.  Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. , 1988, Cancer research.

[43]  F. Rilke,et al.  P53 expression in breast cancer , 1988, International journal of cancer.

[44]  A. Levine,et al.  Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life , 1988, Molecular and cellular biology.

[45]  E. Winter,et al.  Activated ras genes in pulmonary carcinoma , 1988 .

[46]  C. Harris,et al.  Neoplastic transformation of a human bronchial epithelial cell line by a recombinant retrovirus encoding viral harvey ras , 1988, Molecular carcinogenesis.

[47]  C. Harris,et al.  Human bronchial epithelial cells neoplastically transformed by v-Ki-ras: altered response to inducers of terminal squamous differentiation. , 1988, Oncogene research.

[48]  T. O’Toole,et al.  Human adenine phosphoribosyltransferase. Identification of allelic mutations at the nucleotide level as a cause of complete deficiency of the enzyme. , 1987, The Journal of clinical investigation.

[49]  A. Levine,et al.  Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines , 1987, Molecular and cellular biology.

[50]  J. Jenkins,et al.  Mutant p53 proteins bind hsp 72/73 cellular heat shock-related proteins in SV40-transformed monkey cells. , 1987, Oncogene.

[51]  D. Pim,et al.  Primary structure polymorphism at amino acid residue 72 of human p53 , 1987, Molecular and cellular biology.

[52]  K. Mullis,et al.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. , 1987, Methods in enzymology.

[53]  J. Groffen,et al.  Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene. , 1986, Nucleic acids research.

[54]  E. Winter,et al.  A method to detect and characterize point mutations in transcribed genes: amplification and overexpression of the mutant c-Ki-ras allele in human tumor cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[55]  M. Oren,et al.  p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors , 1985, Molecular and cellular biology.

[56]  W. Mercer,et al.  Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes. , 1985, Experimental cell research.

[57]  J. Willey,et al.  Transformation of human bronchial epithelial cells transfected by Harvey ras oncogene. , 1985, Science.

[58]  J. Jenkins,et al.  The cellular oncogene p53 can be activated by mutagenesis , 1985, Nature.

[59]  V. Rotter,et al.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation , 1984, Nature.

[60]  P. Gruss,et al.  Participation of p53 cellular tumour antigen in transformation of normal embryonic cells , 1984, Nature.

[61]  E. Reddy,et al.  Mechanism of activation of an N-ras oncogene of SW-1271 human lung carcinoma cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Barbacid,et al.  Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. , 1984, Science.

[63]  A. Levine,et al.  Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53 , 1983, Molecular and cellular biology.

[64]  E. Fanning,et al.  Specific DNA binding activity of T antigen subclasses varies among different SV40-transformed cell lines. , 1983, Virology.

[65]  A. Levine,et al.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells , 1982, Cell.

[66]  A. Levine,et al.  Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells , 1981, Molecular and cellular biology.

[67]  A. Levine,et al.  Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells , 1979, Cell.

[68]  D. Lane,et al.  T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.

[69]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[70]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.